Greg Kennelty
Articles
Multigene Panel Tests Yield Clues to Breast and Ovarian Cancer Risk
August 03, 2016
Article
What do patients think about being tested for many genes that may impact their hereditary risk for breast or ovarian cancer, beyond the well-known BRCA mutations?
Why BRCA Testing Is So Important for Women With Ovarian Cancer
July 01, 2016
Article
National guidelines recommend that women with a personal history of ovarian cancer be tested for the BRCA mutation. Approximately 1.3% of women will develop ovarian cancer, according to the National Cancer Institute, but that risk increases to an estimated 39% in women with the BRCA1 mutation and 11% to 17% in women who inherit the BRCA2 mutation.
Studies Signal Role for Immunotherapy in Head and Neck Cancer
March 09, 2016
Article
Encouraging findings for PD-1 inhibitor–based immunotherapies for the treatment of patients with metastatic head and neck cancer are emerging from clinical studies.